Blood protein biomarkers in lung cancer

H Huang, Y Yang, Y Zhu, H Chen, Y Yang, L Zhang… - Cancer Letters, 2022 - Elsevier
Lung cancer has consistently ranked first as the cause of cancer-associated mortality. The 5-
year survival rate has risen slowly, and the main obstacle to improving the prognosis of …

Aberrant glycosylation as immune therapeutic targets for solid tumors

Y Matsumoto, T Ju - Cancers, 2023 - mdpi.com
Simple Summary Glycosylation is one of the most pivotal post-translational modifications on
all types of biomolecules for the formation of glycoproteins, glycolipids, and glycoRNAs in a …

Automated lung nodule detection and classification using deep learning combined with multiple strategies

N Nasrullah, J Sang, MS Alam, M Mateen, B Cai, H Hu - Sensors, 2019 - mdpi.com
Lung cancer is one of the major causes of cancer-related deaths due to its aggressive
nature and delayed detections at advanced stages. Early detection of lung cancer is very …

Detection of lung nodule and cancer using novel Mask-3 FCM and TWEDLNN algorithms

L Tiwari, R Raja, V Awasthi, R Miri, GR Sinha… - Measurement, 2021 - Elsevier
Lung Cancer (LC) is reported as common cause of death all over the world. The detection of
cancer can save many lives and help likelihood of survival. Physicians use CT (computed …

The potential role of MUC16 (CA125) biomarker in lung cancer: a magic biomarker but with adversity

HM Saad, GF Tourky, HM Al-Kuraishy, AI Al-Gareeb… - Diagnostics, 2022 - mdpi.com
Lung cancer is the second most commonly diagnosed cancer in the world. In terms of the
diagnosis of lung cancer, combination carcinoembryonic antigen (CEA) and cancer antigen …

Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectives

JB Wang, X Huang, FR Li - Cancer communications, 2019 - Springer
Lung cancer is the leading cause of cancer mortality worldwide. Dendritic cells (DCs) are the
key factors providing protective immunity against lung tumors and clinical trials have proven …

The role of mucin 1 in respiratory diseases

B Ballester, J Milara, J Cortijo - European Respiratory Review, 2021 - Eur Respiratory Soc
Recent evidence has demonstrated that mucin 1 (MUC1) is involved in many pathological
processes that occur in the lung. MUC1 is a transmembrane protein mainly expressed by …

NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy

L Raskova Kafkova, JM Mierzwicka… - Frontiers in …, 2024 - frontiersin.org
Non-small cell lung cancer (NSCLC) is largely promoted by a multistep tumorigenesis
process involving various genetic and epigenetic alterations, which essentially contribute to …

Clinical associations of preoperative and postoperative serum CEA and lung cancer outcome

Z Jiao, S Cao, J Li, N Hu, Y Gong, L Wang… - Frontiers in Molecular …, 2021 - frontiersin.org
Background: Serum carcinoembryonic antigen (CEA), a classic tumour marker, is widely
used in lung cancer in clinical practice. Nevertheless, few studies have elucidated the …

Identification of Tn antigen O-GalNAc-expressing glycoproteins in human carcinomas using novel anti-Tn recombinant antibodies

Y Matsumoto, MR Kudelka, MS Hanes, S Lehoux… - …, 2020 - academic.oup.com
The Tn antigen is a neoantigen abnormally expressed in many human carcinomas and
expression correlates with metastasis and poor survival. To explore its biomarker potential …